Neurofibromin 1 (NF1) is a tumor suppressor, and loss of function mutations occur in this gene in 10–15% of melanomas and are especially prevalent in high-CSD melanomas (i.e., lentigo maligna) [1,5,6,7,9]. This evidence concerns the gene NF1 and melanoma.